BioInformant

Your Global Leader in Stem Cell Market Research

Home » market intelligence » Page 2

Launching June 2016 – Strategic Development of Neural Stem and Progenitor Cell Products

By

Neurogenesis is the process by which neurons are created. This process is most active during pre-natal development when neurogenesis is responsible for populating the growing brain.

Neural stem cells (NSCs) are the self-renewing, multipotent cells that differentiate into the main phenotypes of the nervous system. These cell types include neurons, astrocytes, and oligodendrocytes. Neural progenitor cells (NPCs) are the progeny of stem cell division that normally undergo a limited number of replication cycles in vivo.
 [Read more…]

How to Create Strategically Positioned Stem Cell Product Lines

By

BioInformant, a specialized market research firm serving the life science industry, announces the release of its latest report, “Stem Cell Research Products: Opportunities, Tools & Technologies.” The report combines technology-derived market data with end-user survey findings, exploring current market conditions and providing guidance to companies looking to develop strategically positioned stem cell product lines.

Stem cells are primitive cells found in all multi-cellular organisms that are characterized by self-renewal and the capacity to differentiate into any mature cell type. Several broad categories of stem cells exist, including: embryonic, perinatal, adult, and cancer stem cells. Of interest to researchers is the potential for the use of stem cells in regenerative medicine to treat conditions ranging from diabetes, to cardiovascular disease and neurological disorders. Also, the ability to use stem cells to improve drug target validation and toxicology screening is of intense interest to pharmaceutical companies.

To facilitate this research, a vast stem cell research products market is emerging. Large companies selling stem cell research products include Thermo Fisher Scientific, BD Biosciences, Merck KGaA, Miltenyi Biotec, STEMCELL Technologies, Lonza, Clontech (a Takara Bio Company), and GE Healthcare Life Sciences. Products offered by these companies include: antibodies to stem cell antigens, bead-based stem cell separation systems, stem cell protein purification and analysis tools, tools for DNA and RNA-based characterization of stem cells, stem cell culture and media reagents, stem cell specific growth factors and cytokines, tools for stem cell gene regulation, a range of stem cell services, tools for in vivo and in vitro stem cell tracking, and stem cell lines.

“A more in-depth understanding of the needs of scientists studying stem cells is of growing importance as the field becomes more complex and funding sources become harder to obtain,” explained Cade Hildreth, President/CEO of BioInformant.com.

This market report includes:

  • An overview of stem cell research applications, including priorities by segment
  • A breakdown of stem cell product categories
  • Market assessment, including grant, patent, clinical trial, and scientific publication rate analysis
  • Overview of stem cell funding sources, trends, and amounts (domestic and international)
  • Market size valuations
  • Historical and future growth projections for the stem cell research products market
  • Competitive analysis of stem cell research product companies
  • Communications strategies for accessing the marketplace
  • End-user survey of stem cell scientists

Released February 2016, “Stem Cell Research Products: Opportunities, Tools & Technologies ” explores current market conditions within the stem cell research products market, provides strategic guidance for competing within the industry, and quantifies important trends, metrics, and findings to guide the decision-making of competitors across the stem cell research products marketplace.

Click here to view the full Executive Summary and Table of contents for the report: https://bioinformant.wpengine.com/product/stem-cell-research-products-opportunities-tools-and-technologies/.

Want to be better informed than your competition? Get future stem cell industry updates.

 

About Us

BioInformant is the only research firm that has served the stem cell sector since it emerged. Our management team comes from a BioInformatics background – the science of collecting and analyzing complex genetic codes – and applies these techniques to the field of market research. BioInformant research has been cited by major news outlets that include the Wall Street Journal, Nature Biotechnology, CBS News, Medical Ethics, and the Center for BioNetworking. Serving Fortune 500 leaders that include GE Healthcare, Pfizer, Goldman Sachs, and Becton Dickinson, BioInformant is your global leader in stem cell industry data.

Click here to view our global strategic reports for the stem cell and cord blood industry.

ViaCord Finds Ultimate Solution to Cord Blood Marketing – Aligns with the World’s Largest Retailer of Maternity Clothing

By

An interesting partnership within the cord blood marketplace is between the second largest cord blood bank in the world, ViaCord, and the world’s largest designer and retailer of women’s maternity clothing, Destination Maternity. Headquartered in Philadelphia, Pennsylvania, USA, Destination Maternity operates 2,008 retail locations, including 625 stores, largely under the trade names Destination Maternity, Motherhood Maternity, and A Pea in the Pod.[1]

Based on the lack of competing offers, ViaCord appears to have exclusive rights to have its cord blood banking educational materials placed in the checkout bags of clients purchasing maternity items at Destination Maternity retail stores. [Read more…]

How 1.2 Trillion Online Searches Identified “Cell Therapy” as an Early-Stage Market

By

According to Internet Live Stat, Google now processes over 3.5 billion searches per day and 1.2 trillion searches per year. That is a massive amount of searches, especially when put into the context of there being approximately 7.4 billion people on earth.  

Therefore, one of the single best resources for analyzing new market directions and the relative importance of specific geographic regions is Google Trends.1 In addition to reflecting online search behavior,  Google Trends is an excellent tool for geographic analysis.

In the analysis below, the term “cell therapy” is searched within Google Trends to produce fascinating global findings.

Below, the number of online searches for the term “cell therapy” is shown, with the data plotted over a 10-year period. [Read more…]

How Market Intelligence Can Change Your Cord Blood Bank (Overnight)

By

No. Your Cord Blood Bank Does Not Have to Grow Slowly. 

As I hung up the phone, one sentence hung in my mind:

“I realized in my first read-through that there are more than a dozen triggers that could grow my cord blood bank – not tomorrow, now.”

This statement was part of a phone conversation I had with a client this week who took the time to thank me for his decision to invest in the “Complete 2015-16 Global Cord Blood Banking Industry Report.” He admitted that when he researched the product, he broadly searched for business intelligence about the cord blood marketplace.

However, after settling on the “Complete 2015-16 Global Cord Blood Banking Industry Report” as the only product in the marketplace that contains business intelligence data – i.e. data that analyzes competitive business opportunities and conditions – he found that this product had several qualities that differentiated it within the marketplace and made it essential to the management decisions that he has to make within his cord blood bank. [Read more…]

BioInformant's World-Class Clients